Home Johnson & Johnson's Stelara Succeeds In Phase III Crohn's Disease Trial
 

Keywords :   


Johnson & Johnson's Stelara Succeeds In Phase III Crohn's Disease Trial

2015-10-19 19:30:37| Food - Topix.net

Johnson & Johnson's Stelara was significantly better than placebo at inducing clinical response and remissions in patients with moderate to severe Crohn's disease, according to data from a late stage trial, providing ammunition for a potential expanded approval of the medicine. Stelara, a biotech medicine that blocks inflammation, is approved to treat the skin condition scaly plaque psoriasis and a type of arthritis associated with psoriasis.

Tags: iii trial phase disease

Category:Food and Related Products

Latest from this category

All news

»
23.11Idées de CADRES No.83
23.11 12BOX PREMIUMpack 25th
23.11V2box
23.11
23.11 &
23.11DVD('97/)E11387
23.117
23.11
More »